These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 15312960
1. Species-specific immune response to immunization with human versus rodent A beta peptide. Seabrook TJ, Bloom JK, Iglesias M, Spooner ET, Walsh DM, Lemere CA. Neurobiol Aging; 2004 Oct; 25(9):1141-51. PubMed ID: 15312960 [Abstract] [Full Text] [Related]
2. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice. Seabrook TJ, Thomas K, Jiang L, Bloom J, Spooner E, Maier M, Bitan G, Lemere CA. Neurobiol Aging; 2007 Jun; 28(6):813-23. PubMed ID: 16725229 [Abstract] [Full Text] [Related]
3. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. Nat Med; 2000 Aug; 6(8):916-9. PubMed ID: 10932230 [Abstract] [Full Text] [Related]
4. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses. Chackerian B, Rangel M, Hunter Z, Peabody DS. Vaccine; 2006 Sep 11; 24(37-39):6321-31. PubMed ID: 16806604 [Abstract] [Full Text] [Related]
5. Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice. Seabrook TJ, Iglesias M, Bloom JK, Spooner ET, Lemere CA. Vaccine; 2004 Sep 28; 22(29-30):4075-83. PubMed ID: 15364459 [Abstract] [Full Text] [Related]
6. Recombinant GST-I-A beta 28-induced efficient serum antibody against A beta 42. Huang X, Wang J, Cui L, Zou X, Zhang Y. J Neurosci Methods; 2010 Jan 30; 186(1):52-9. PubMed ID: 19900475 [Abstract] [Full Text] [Related]
7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T, Kiliaan AJ, Kadish I. Neurobiol Dis; 2006 Sep 30; 23(3):653-62. PubMed ID: 16829076 [Abstract] [Full Text] [Related]
8. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels. Rakover I, Arbel M, Solomon B. Neurodegener Dis; 2007 Sep 30; 4(5):392-402. PubMed ID: 17536186 [Abstract] [Full Text] [Related]
9. Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice. Bach P, Tschäpe JA, Kopietz F, Braun G, Baade JK, Wiederhold KH, Staufenbiel M, Prinz M, Deller T, Kalinke U, Buchholz CJ, Müller UC. J Immunol; 2009 Jun 15; 182(12):7613-24. PubMed ID: 19494285 [Abstract] [Full Text] [Related]
10. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies. Geylis V, Steinitz M. Autoimmun Rev; 2006 Jan 15; 5(1):33-9. PubMed ID: 16338209 [Abstract] [Full Text] [Related]
11. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele. Zota V, Nemirovsky A, Baron R, Fisher Y, Selkoe DJ, Altmann DM, Weiner HL, Monsonego A. J Immunol; 2009 Sep 01; 183(5):3522-30. PubMed ID: 19675171 [Abstract] [Full Text] [Related]
12. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques. Poduslo JF, Ramakrishnan M, Holasek SS, Ramirez-Alvarado M, Kandimalla KK, Gilles EJ, Curran GL, Wengenack TM. J Neurochem; 2007 Jul 01; 102(2):420-33. PubMed ID: 17596213 [Abstract] [Full Text] [Related]
13. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response. Zou J, Yao Z, Zhang G, Wang H, Xu J, Yew DT, Forster EL. J Neurol Sci; 2008 Sep 15; 272(1-2):87-98. PubMed ID: 18571202 [Abstract] [Full Text] [Related]
14. Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes. Esposito M, Luccarini I, Cicatiello V, De Falco D, Fiorentini A, Barba P, Casamenti F, Prisco A. Mol Immunol; 2008 Feb 15; 45(4):1056-62. PubMed ID: 17850871 [Abstract] [Full Text] [Related]
15. Active immunization trial in Abeta42-injected P301L tau transgenic mice. Kulic L, Kurosinski P, Chen F, Tracy J, Mohajeri MH, Li H, Nitsch RM, Götz J. Neurobiol Dis; 2006 Apr 15; 22(1):50-6. PubMed ID: 16289870 [Abstract] [Full Text] [Related]
16. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice. Xing XN, Zhang WG, Sha S, Li Y, Guo R, Wang C, Cao YP. Chin Med J (Engl); 2011 Sep 15; 124(17):2636-41. PubMed ID: 22040416 [Abstract] [Full Text] [Related]
17. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology. Solomon B. Vaccine; 2007 Apr 20; 25(16):3053-6. PubMed ID: 17287054 [Abstract] [Full Text] [Related]
18. Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice. Sohn JH, So JO, Kim H, Nam EJ, Ha HJ, Kim YH, Mook-Jung I. Biochem Biophys Res Commun; 2007 Sep 28; 361(3):800-4. PubMed ID: 17678618 [Abstract] [Full Text] [Related]
19. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination. Solomon B. Vaccine; 2005 Mar 18; 23(17-18):2327-30. PubMed ID: 15755621 [Abstract] [Full Text] [Related]
20. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain. Kim HD, Kong FK, Cao Y, Lewis TL, Kim H, Tang DC, Fukuchi K. Neurosci Lett; 2004 Nov 11; 370(2-3):218-23. PubMed ID: 15488326 [Abstract] [Full Text] [Related] Page: [Next] [New Search]